1. Prevalence and Prognostic Impact of Equus caballus Papillomavirus Type 2 Infection in Equine Squamous Cell Carcinomas in Western Canadian Horses.
- Author
-
Greenwood S, Chow-Lockerbie B, Epp T, Knight C, Wachoski-Dark G, MacDonald-Dickinson V, and Wobeser B
- Subjects
- Animals, Canada epidemiology, Carcinoma, Squamous Cell diagnosis, Carcinoma, Squamous Cell epidemiology, Female, Genitalia virology, Horse Diseases epidemiology, Horse Diseases virology, Horses, In Situ Hybridization veterinary, Male, Papillomaviridae genetics, Papillomavirus Infections diagnosis, Papillomavirus Infections epidemiology, Papillomavirus Infections virology, Polymerase Chain Reaction veterinary, Prevalence, Prognosis, Retrospective Studies, Survival Analysis, Carcinoma, Squamous Cell veterinary, Horse Diseases diagnosis, Papillomaviridae isolation & purification, Papillomavirus Infections veterinary
- Abstract
Equus caballus papillomavirus type-2 (EcPV-2) has been proposed as a causal factor in equine genital squamous cell carcinoma (SCC). This study had 2 objectives: first, calculate the frequency of papillomavirus (PV) and EcPV-2 infection in papillomas, carcinomas in situ (CIS), and SCCs in Western Canadian horses; and second, determine if EcPV-2 status of equine SCCs is associated with overall survival (OS). EcPV-2 status of 115 archived tissue samples, spanning 6 years, was determined using broad spectrum (MY09/11) and EcPV-2-specific polymerase chain reaction (PCR) assays, EcPV-2-E6/E7 chromogenic RNA in situ hybridization (R-ISH), and amplicon sequencing. A retrospective survey gathered data on history, outcome, breeding, treatment, and rationales of referring veterinarians when managing PV-associated diseases. Histologic grade and completeness of surgical margins of SCCs were also considered. EcPV-2 DNA was identified in 10/58 (17%) SCC, 8/27 (30%) papillomas, 0/5 CIS, and 0/11 lesions identified as "other." Overall, 18/101 (18%) of these lesions were positive for EcPV-2. EcPV-2 was identified in 10/35 (29%) SCCs arising from genital tissues but in 0/22 SCCs from other locations. There was no association between breeding history and EcPV-2 status of genital SCCs. EcPV-2 status of genital SCCs was not associated with OS ( P = .76). The strongest negative predictors of OS were a lack of treatment ( P < .01) and recurrence post-treatment ( P < .01). Weaker predictors of OS included older age at time of diagnosis ( P = .02). Completeness of margins at surgical excision, concurrent disease, treatment type, anatomic location of the SCC (anogenital vs other), and histologic grade of the SCC did not influence OS ( P > .1).
- Published
- 2020
- Full Text
- View/download PDF